Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.
New data on antimicrobial resistance in Europe New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw
Vaccination rate increased, HPV even significantly For the first time in five years, the number of children receiving vaccinations from the National Immunisation Programme has increased slightly.
Antimicrobial resistance stable in the Netherlands Worldwide, the number of bacteria resistant to antibiotics is increasing. In the Netherlands, this number generally remains stable and is less high than in many other countries.
Corona crisis has limited impact on infant participation in National Immunisation Programme Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.
Research: HPV vaccine is safe RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.
Teen vaccination against meningococcal disease starts From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.